Showing results (131-140 of 180) with videos related to
Sort By:
Pageof 18
British Journal of Haematology|October 15, 2014
Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemiaRosemary Sutton, Peter J Shaw, Nicola C Venn, et al.Antimicrobial Agents and Chemotherapy|August 18, 2025
Cytomegalovirus prophylaxis with letermovir in pediatric (birth to <18 years of age) hematopoietic cell transplant recipients: pharmacokinetics, efficacy, and safety results of a Phase 2b studyAndreas H Groll, Lara Danziger-Isakov, Aharon Gefen, et al.Blood Advances|January 4, 2018
Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cellsBarbara Withers, Emily Blyth, Leighton E Clancy, et al.Blood|March 24, 2017
Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biologyLenka Hovorkova, Marketa Zaliova, Nicola C Venn, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 14, 2013
Effect of weight and maturation on busulfan clearance in infants and small children undergoing hematopoietic cell transplantationRadojka M Savic, Morton J Cowan, Christopher C Dvorak, et al.Journal of Paediatrics and Child Health|October 25, 2020
Diagnosis and management of severe combined immunodeficiency in Australia and New ZealandStephanie Richards, Andrew R Gennery, E Graham Davies, et al.Blood Advances|July 12, 2022
Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplantWei Jiang, Leighton E Clancy, Selmir Avdic, et al.Haematologica|March 4, 2017
A risk factor analysis of outcomes after unrelated cord blood transplantation for children with Wiskott-Aldrich syndromeZhanna Shekhovtsova, Carmem Bonfim, Annalisa Ruggeri, et al.Transplantation and Cellular Therapy|September 27, 2021
Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 PandemicDuncan Purtill, Cheryl Hutchins, Glen Kennedy, et al.Transfusion|January 21, 2021
A multicenter report on the safety and efficacy of plerixafor based stem cell mobilization in children with malignant disordersNabanita Bhunia, Rolla Abu-Arja, Joseph R Stanek, et al.Pageof 18